UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 174

Sortiert nach

Therapeutic trial of metformin and bortezomib in a mouse model of tuberous sclerosis complex (TSC)

PloS one, 2012-02, Vol.7 (2), p.e31900-e31900

2012

Link zum Volltext

Verfügbarkeit prüfen

PI3K/mTOR Pathway Inhibition: Opportunities in Oncology and Rare Genetic Diseases

International journal of molecular sciences, 2019-11, Vol.20 (22), p.5792

2019

Link zum Volltext

Verfügbarkeit prüfen

Emerging Link between Tsc1 and FNIP Co-Chaperones of Hsp90 and Cancer

Biomolecules (Basel, Switzerland), 2022-07, Vol.12 (7), p.928

2022

Link zum Volltext

Verfügbarkeit prüfen

Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful treatment of a rare malignancy

Journal for immunotherapy of cancer, 2018-10, Vol.6 (1), p.97-97, Article 97

2018

Link zum Volltext

Verfügbarkeit prüfen

Energy Stress-Mediated Cytotoxicity in Tuberous Sclerosis Complex 2-Deficient Cells with Nelfinavir and Mefloquine Treatment

Cancers, 2018-10, Vol.10 (10), p.375

2018

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of the mechanistic target of rapamycin induces cell survival via MAPK in tuberous sclerosis complex

Orphanet journal of rare diseases, 2020-08, Vol.15 (1), p.209-209, Article 209

2020

Link zum Volltext

Verfügbarkeit prüfen

Expression and Prognostic Value of Oct-4 in Astrocytic Brain Tumors

PloS one, 2016-12, Vol.11 (12), p.e0169129-e0169129

2016

Link zum Volltext

Verfügbarkeit prüfen

Binding Models of Copper(II) Thiosemicarbazone Complexes with Human Serum Albumin: A Speciation Study

Molecules (Basel, Switzerland), 2021-05, Vol.26 (9), p.2711

2021

Link zum Volltext

Verfügbarkeit prüfen

Anti-EGFR Antibody Reduces Lung Nodules by Inhibition of EGFR-Pathway in a Model of Lymphangioleiomyomatosis

BioMed research international, 2015-01, Vol.2015, p.315240-14

2015

Link zum Volltext

Verfügbarkeit prüfen

Tuberous sclerosis complex: a complex case

Cold Spring Harbor molecular case studies, 2022-04, Vol.8 (3), p.1

2022

Link zum Volltext

Verfügbarkeit prüfen

Appetite for destruction: the inhibition of glycolysis as a therapy for tuberous sclerosis complex-related tumors

BMC biology, 2011-10, Vol.9 (1), p.69-69, Article 69

2011

Link zum Volltext

Verfügbarkeit prüfen

Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer

PloS one, 2016-04, Vol.11 (4), p.e0152584-e0152584

2016

Link zum Volltext

Verfügbarkeit prüfen

Rapamycin-independent IGF2 expression in Tsc2-null mouse embryo fibroblasts and human lymphangioleiomyomatosis cells

PloS one, 2018-05, Vol.13 (5), p.e0197105-e0197105

2018

Link zum Volltext

Verfügbarkeit prüfen

HHLA2 Used as a Potential Prognostic and Immunological Biomarker and Correlated with Tumor Microenvironment in Pan-Cancer

BioMed research international, 2022-02, Vol.2022, p.3924400-21

2022

Link zum Volltext

Verfügbarkeit prüfen

p53-mediated autophagic regulation: A prospective strategy for cancer therapy

Cancer letters, 2015-07, Vol.363 (2), p.101-107

2015

Link zum Volltext

Verfügbarkeit prüfen

Translation initiation factor eIF2a serine 51 phosphorylation couples with the mammalian target of rapamycin (mTOR) to determine cell fate and tumorigenesis under stress

European journal of cancer (1990), 2016-12, Vol.69, p.S141

Koromilas, A

2016

Link zum Volltext

Verfügbarkeit prüfen

Triapine-mediated ABCB1 induction via PKC induces widespread therapy unresponsiveness but is not underlying acquired triapine resistance

Cancer letters, 2015-05, Vol.361 (1), p.112-120

2015

Link zum Volltext

Verfügbarkeit prüfen

Insights into Overlappings of Fibrosis and Cancer: Exploring the Tumor-related Cardinal Genes in Idiopathic Pulmonary Fibrosis

Iranian journal of allergy, asthma, and immunology, 2023-04, Vol.22 (2), p.190

2023

Link zum Volltext

Verfügbarkeit prüfen

Combination of Fish Oil and Selenium Enhances Anticancer Efficacy and Targets Multiple Signaling Pathways in Anti-VEGF Agent Treated-TNBC Tumor-Bearing Mice

Marine drugs, 2021-03, Vol.19 (4), p.193

2021

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Hsp90 and mTOR inhibitors as potential drugs for the treatment of TSC1/TSC2 deficient cancer

PloS one, 2021-04, Vol.16 (4), p.e0248380-e0248380

2021

Link zum Volltext

Verfügbarkeit prüfen

Analysis of TSC2 stop codon variants found in tuberous sclerosis patients

European journal of human genetics : EJHG, 2001-11, Vol.9 (11), p.823-828

2001

Link zum Volltext

Verfügbarkeit prüfen

Cancer cell survival depends on collagen uptake into tumor-associated stroma

Nature communications, 2022-11, Vol.13 (1), p.7078-7078, Article 7078

2022

Link zum Volltext

Verfügbarkeit prüfen

Neuronatin in a subset of glioblastoma multiforme tumor progenitor cells is associated with increased cell proliferation and shorter patient survival

PloS one, 2012-05, Vol.7 (5), p.e37811-e37811

2012

Link zum Volltext

Verfügbarkeit prüfen

mTOR Signaling Network in Cell Biology and Human Disease

International journal of molecular sciences, 2022-12, Vol.23 (24), p.16142

2022

Link zum Volltext

Verfügbarkeit prüfen

Modulation of Intracellular Copper Levels as the Mechanism of Action of Anticancer Copper Complexes: Clinical Relevance

Biomedicines, 2021-07, Vol.9 (8), p.852

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 174

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Complete

ThemaCancer

ThemaProteins

ThemaTumors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(172)
Mit Volltextzugriff
(170)

Publikationsform

Artikel
(172)
Dissertationen
(2)

Sprache

Englisch
(173)
Japanisch
(34)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

12 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(27)
Cancers
(18)
International Journal Of Molecular Sciences
(13)
Cancer Letters
(8)
Cells
(6)
Cancer Cell International
(5)
Biomed Research International
(4)
Biomolecules
(4)
Disease Models & Mechanisms
(4)
Plos Genetics
(4)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Therapeutic trial of metformin and bortezomib in a mouse model of tuberous sclerosis complex (TSC)

PI3K/mTOR Pathway Inhibition: Opportunities in Oncology and Rare Genetic Diseases

Emerging Link between Tsc1 and FNIP Co-Chaperones of Hsp90 and Cancer

Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful treatment of a rare malignancy

Energy Stress-Mediated Cytotoxicity in Tuberous Sclerosis Complex 2-Deficient Cells with Nelfinavir and Mefloquine Treatment

Inhibition of the mechanistic target of rapamycin induces cell survival via MAPK in tuberous sclerosis complex

Expression and Prognostic Value of Oct-4 in Astrocytic Brain Tumors

Binding Models of Copper(II) Thiosemicarbazone Complexes with Human Serum Albumin: A Speciation Study

Anti-EGFR Antibody Reduces Lung Nodules by Inhibition of EGFR-Pathway in a Model of Lymphangioleiomyomatosis

Tuberous sclerosis complex: a complex case

Appetite for destruction: the inhibition of glycolysis as a therapy for tuberous sclerosis complex-related tumors

Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer

Rapamycin-independent IGF2 expression in Tsc2-null mouse embryo fibroblasts and human lymphangioleiomyomatosis cells

HHLA2 Used as a Potential Prognostic and Immunological Biomarker and Correlated with Tumor Microenvironment in Pan-Cancer

p53-mediated autophagic regulation: A prospective strategy for cancer therapy

Translation initiation factor eIF2a serine 51 phosphorylation couples with the mammalian target of rapamycin (mTOR) to determine cell fate and tumorigenesis under stress

Triapine-mediated ABCB1 induction via PKC induces widespread therapy unresponsiveness but is not underlying acquired triapine resistance

Insights into Overlappings of Fibrosis and Cancer: Exploring the Tumor-related Cardinal Genes in Idiopathic Pulmonary Fibrosis

Combination of Fish Oil and Selenium Enhances Anticancer Efficacy and Targets Multiple Signaling Pathways in Anti-VEGF Agent Treated-TNBC Tumor-Bearing Mice

Evaluation of Hsp90 and mTOR inhibitors as potential drugs for the treatment of TSC1/TSC2 deficient cancer

Analysis of TSC2 stop codon variants found in tuberous sclerosis patients

Cancer cell survival depends on collagen uptake into tumor-associated stroma

Neuronatin in a subset of glioblastoma multiforme tumor progenitor cells is associated with increased cell proliferation and shorter patient survival

mTOR Signaling Network in Cell Biology and Human Disease

Modulation of Intracellular Copper Levels as the Mechanism of Action of Anticancer Copper Complexes: Clinical Relevance

Aktive Filter

Suchergebnisse filtern